Biogen (BIIB) EBT Margin (2009 - 2026)

Biogen has reported EBT Margin for 18 years, with the latest figure at 4.84% in Q2 2026.

• On a quarterly basis, EBT Margin fell 2328.0% year-over-year to 4.84% in Q2 2026; TTM through Jun 2026 was 10.09%, a 790.0% decrease from a year earlier, with the FY2025 full-year figure at 15.74%, down 396.0% from the prior year.
• EBT Margin was 4.84% for Q2 2026 at Biogen, down from 15.24% in the prior quarter.
• The five-year high for EBT Margin was 54.66% in Q3 2022, with the low at 5.58% in Q3 2023.
• Average EBT Margin over 5 years is 19.65%, with a median of 18.04% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT Margin surged 4418 bps in 2022, then sank 6024 bps in 2023.
• Over 5 years, EBT Margin stood at 23.73% in 2022, then tumbled by 49 bps to 12.22% in 2023, then declined by 3 bps to 11.88% in 2024, then sank by 121 bps to 2.46% in 2025, then jumped by 297 bps to 4.84% in 2026.
• The last three EBT Margin figures came in at 4.84% (Q2 2026), 15.24% (Q1 2026), and 2.46% (Q4 2025), per Business Quant data.